Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.400
+0.010 (0.42%)
Dec 5, 2025, 4:00 PM EST - Market closed
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Perspective Therapeutics stock have an average target of 11.56, with a low estimate of 7.00 and a high estimate of 16. The average target predicts an increase of 381.67% from the current stock price of 2.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 6 |
| Buy | 6 | 6 | 6 | 5 | 5 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 10 | 11 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Initiates $8 → $12 | Strong Buy | Initiates | $8 → $12 | +400.00% | Nov 24, 2025 |
| UBS | UBS | Strong Buy Maintains $18 → $7 | Strong Buy | Maintains | $18 → $7 | +191.67% | Nov 21, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +358.33% | Nov 18, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +483.33% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +483.33% | Oct 10, 2025 |
Financial Forecast
Revenue This Year
1.12M
from 1.45M
Decreased by -22.76%
Revenue Next Year
894.34K
from 1.12M
Decreased by -20.36%
EPS This Year
-1.27
from -1.23
EPS Next Year
-1.33
from -1.27
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.4M | 1.5M | ||||
| Avg | 1.1M | 894,336 | ||||
| Low | 824,180 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.8% | 30.9% | ||||
| Avg | -22.8% | -20.4% | ||||
| Low | -43.3% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.10 | -0.99 | ||||
| Avg | -1.27 | -1.33 | ||||
| Low | -1.30 | -1.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.